RDGL RDGL

Vivos (QB) Stock Price

0.0577
-0.0003 (-0.52%)
0.0577
Volume 1,117,260
Bid Price 0.0521
Ask Price 0.058
News -
Day High 0.059

Low
0.0405

52 Week Range

High
0.1395

Day Low 0.052
Company Name Stock Ticker Symbol Market Type
Vivos Inc (QB) RDGL OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -0.52% 0.0577 16:00:05
Open Price Low Price High Price Close Price Prev Close
0.059 0.052 0.059 0.0577 0.058
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
68 1,117,260 $ 0.055816 $ 62,361 - 0.0405 - 0.1395
Last Trade Time Type Quantity Stock Price Currency
15:31:32 10,000 $ 0.0577 USD

Period:

Draw Mode:

Vivos Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 20.64M 357.74M 288.08M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
16.09k $ - - - -

more financials information »

Vivos (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RDGL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.060.0650.0520.0590196639,125-0.0023-3.83%
1 Month0.06990.0710.0520.0614686523,861-0.0122-17.45%
3 Months0.08750.08750.0520.0690363430,408-0.0298-34.06%
6 Months0.06610.12640.04050.0708901481,100-0.0084-12.71%
1 Year0.0952450.13950.04050.0834264670,879-0.03755-39.42%
3 Years0.040.310.01350.09576311,195,0080.017744.25%
5 Years0.0750.310.00240.02574054,246,222-0.0173-23.07%

Vivos (QB) Description

Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially available for animal therapy and can deliver very high doses to solid tumors with a single same day therapy. Pre-clinical testing is in progress to generate key data for an Investigational Devise Exemption to the FDA to begin human clinical trials.


Your Recent History
USOTC
RDGL
Vivos (QB)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now